Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Dongguan
Clinical trial register · China

Clinical Trials in Dongguan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 5586 Shanghai 3885 Guangzhou 3356 Hangzhou 1825 Wuhan 1342
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University15 AstraZeneca12 Nanfang Hospital, Southern Medical University5 Biogen4 Akeso4 GlaxoSmithKline4 Janssen Research & Development, LLC3 Sanofi3 MediLink Therapeutics (Suzhou) Co., Ltd.2 Johnson & Johnson Enterprise Innovation Inc.2 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.2 Shanghai Henlius Biotech2 Guangdong Provincial People's Hospital2 Sun Yat-Sen University Cancer Center2 Alexion Pharmaceuticals, Inc.2 Guangdong Association of Clinical Trials2 DualityBio Inc.2 Pfizer2 Sichuan Baili Pharmaceutical Co., Ltd.2 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 Merck Sharp & Dohme LLC2 Zhuliling1 Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 Third Affiliated Hospital, Sun Yat-Sen University1 Tasly Pharmaceutical Group Co., Ltd1 CSL Behring1 Amgen1 Shanghai Huilun Pharmaceutical Co., Ltd.1 TJ Biopharma Co., Ltd.1 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 Zhongshan Ophthalmic Center, Sun Yat-sen University1 Fifth Affiliated Hospital, Sun Yat-Sen University1 The First Affiliated Hospital with Nanjing Medical University1 Beijing InnoCare Pharma Tech Co., Ltd.1 Guangdong Raynovent Biotech Co., Ltd1 OncoC4, Inc.1 Multitude Therapeutics Inc.1 Novartis Pharmaceuticals1 Innovent Biologics (Suzhou) Co. Ltd.1 Beijing Tiantan Hospital1 Alpine Immune Sciences Inc, A Subsidiary of Vertex1 Liu yong1 Dongguan People's Hospital1 Boehringer Ingelheim1 Bellus Health Inc. - a GSK company1 RemeGen Co., Ltd.1 Vertex Pharmaceuticals Incorporated1 3D Medicines (Sichuan) Co., Ltd.1 Sunshine Lake Pharma Co., Ltd.1 Peking Union Medical College Hospital1 Betta Pharmaceuticals Co., Ltd.1
Site location
Beijing5586 Shanghai3885 Guangzhou3356 Hangzhou1825 Wuhan1342 Chengdu1310 Nanjing1213 Changsha1159 Chongqing1081 Fuzhou1043 Tianjin937 Zhengzhou930 Hefei901 Jinan788 Changchun640 Shenzhen582 Harbin549 Nanchang445 Xi'an442 Nanning439 Suzhou427 Shenyang407 Xiamen392 Shijiazhuang348 Lanzhou272 Bengbu218 Wenzhou189 Kunming187 Guiyang182 Qingdao171 Luoyang156 Ningbo152 Taiyuan148 Foshan144 Dalian135 Xuzhou134 Haikou124 Changzhou124 Dongguan106 Shantou101 Nantong99 Hong Kong98 Wuhu92 Wuxi84 Huizhou83 Baoding83 Anyang83 Baotou82 Zhuhai79 Guangdong76 Xi’an71 Liuzhou70 Cangzhou63 Zhongshan60 Hohhot59 Ganzhou57 Xinxiang57 Taizhou55 Yangzhou55 Jiangmen54 Guilin54 Ürümqi52 Guanzhou51 Yiwu50 Zhanjiang48 Zhejiang47 Yinchuan47 Linyi47 Meizhou46 Fuyang46 Nanyang45 Zunyi45 Zhangzhou44 Quanzhou43 Jinhua43 Hanzhou42 Changde42 Lishui42 Huzhou41 Huai'an39 Langfang38 Jining37 Jiaxing37 Fujian36 Tangshan35 Jilin City34 Xiangyang32 Hunan31 Xining31 Henan31 Binzhou30 Daqing30 Kaifeng29 Shandong28 Yantai28 Changzhi28 Chifeng28 Yichang27 Hengyang27 Chengde27 Xingtai26 Sichuan25 Jingzhou25 Xianyang24 Hubei24 Weifang23 Mianyang23 Shiyan23 Wuzhou22 Hebei22 Haerbin21 Luzhou21 Lianyungang21 Wuwei21 Jiamusi20 Shaoguan19 Nanchong19 Deyang19 Bozhou18 Zhenjiang18 Liaocheng18 Anqing18 Chenzhou18 Putian18 Shanxi18 Yancheng18 Shaoxing17 Handan16 Qingyuan16 Quzhou16 Zibo15 Yulin15 Qinhuangdao15 Shangqiu15 Chizhou15 Guangxi14 Xian14 Maoming14 Pingxiang14 Luoyang Shi14 Haidian13 Guizhou13 Heilongjiang13 Zhenzhou12 Xiangtan12 Dongyang12 Jiaozuo12 Shengyang12 Ha’erbin12 Linfen11 Nanjin11 Kunshan11 Chaoyang11 Huaian11 Yan’an11 Ma’anshan11 Suqian11 Beijin11 Guandong11 Huanggang10 Jiujiang10 Qionghai10 Zhuzhou10 Ankang10 Jieyang10 Longyan10 Heyuan10 Tianjing10 Baise City10 Guigang9 Tongling9 Weinan9 Chuzhou9 Hanzhong9 Neijiang9 Liupanshui8 Heze8 Yueyang8 Zigong8 Jiangxi8 Linhai8 Zhaoqing8 Huaihua8 Shaoyang8 Tai’an8 Qinzhou8 Zhoukou8 Dezhou7 Dongying7 Xuchang7 Hengshui7 Shenzhen Shi7 Ch’ang-ch’un7 Zhangjiakou7 Anhui7 Jinjiang7 Sanming7 Fuzhou Fujian7 Hainan7 Cheng Du Shi7 Lu'an7 Yibin7 Sanya7 Dali7 Huainan7 Baoji7 Xicheng7 Kashgar6 Puyang6 Huangshi6 Suining6 Jinzhou6 Meihekou6 Luohe6 Xuancheng6 Chaoyang District6 Zhoushan6 Kaili6 China6 Yuncheng6 Shanghai Shi6 Naning6 Xuhui6 Dazhou6 Macao5 Enshi5 Anshan5 Yuzhong5 Yixing5 Datong5 Yuhuan5 Dongcheng5 Panjin5 Sanmenxia5 Qianjiang5 Shihezi5 Wanzhou5 Changping5 Jiazhuang5 Mudanjiang5 Haidian District5 Tongliao5 Lanxi5 Bijie5 Zhumadian5 Wenling4 Jiangsu4 Weihai4 Xianning4 Taian4 Benxi4 Qinghai4 Huangshan City4 Ya'an4 Ningde4 Hezhou4 Suzhu4 Jiangyin4 Ji'nan4 Qiqihar4 Chaohu4 Pudong4 Changshu4 Jingdezhen4 Yongzhou4 Multiple Locations4 Jiuquan4 Huangpu4 Gaozhou4 Anning4 Chendu4 Yunnan3 Aksu3 Yanan3 Beijingcun3 Shanwei3 Shunde3 Zhujiang3 Changsha Shi3 Rizhao3 Shapingba3 Bishan3 Dongwan3 Anshun3 Minhang District3 Gansu3 Binhai3 Huaibei3 Chongqicun3 Dengzhou3 Yangpu3 Shang'ai3 Loudi3 Leshan3 Ji’an3 Xingyi3 Guankou3 Fushun3 Fuxin3 Guangdong Province3 Hebi3 Yangjiang3 Neimeng3 Jiyuan3 Zhangjiang3 Lhasa3 Weihui3 Beihai3 Xinjiang3 Yunfu3 Linqing2 Maanshan2 Meishan2 Liangyugang2 Ninghai2 Fuling2 Hechuan2 Yichang Shi2 Guiping2 Karamay2 Taipei2 Ningxia2 Xigazê2 Inner Mongolia2 Pingdingshan2 Yichun2 Herbin2 Gongshu District2 Chongqi2 Tongzhou2 Meicheng2 Tongren2 Baotou Shi2 Xuhui District2 Shatin2 Changzhou Shi2 Hechi2 Jishou2 Huayuan2 Dangyang2 Yixingcun2 Dandong2 Zaozhuang2 Yueqing2 Chibi2 Jingjiang2 Suizhou2 Xiaogan2 Jing’an2 Haozhou2 Dingxi2 Changle2 Macau2 Panlong2 Guli2 Many Locations2 Yisa2 Shanhai2 Lincang2 Xicheng District2 Fengtai2 Jincheng2 Rui’an2 Yiyang2 Xinyang2 Danyang2 Qiandongnan Miao and Dong Autonomous Prefecture2 Qiannan2 Jiaxin2 Xiantao2 Tianshui2 Jinzhong2 Guangyuan2 Nan'ning2 Taiwan2 Qujing2 Taihe Chengguanzhen2 Anxi2 Changlexi2 Hetian1 Yangcheng1 Chengdoucun1 Feicheng1 Jingmen1 Chengdu, Sichuan1 Chancheng District1 Liwan District1 North Street1 Nanshan District1 Luoyan1 Hami1 Liu‘an1 Xianmencun1 Zhenngzhou1 Xichengqu Beijing1 Beijing Sheng1 Gunan1 Jiangjin1 Wulong1 Sanhe1 Ruyang1 Qidong1 Xiangya1 Tongji1 Wujin District1 Guangong Apt/Yuncheng1 Chaozhou1 Jimsar1 Luopu1 Yining1 Tainan1 Taoyuan1 Changchuan1 Guangzhusi1 Zhuozhou1 Fyzhou1 Qingyang1 Lingchuan1 Xing’an1 Daming1 Dingxing1 Zhengding1 Wenquan1 Shangluo1 Ji'an1 Dexing1 Wanzai1 Linxia1 Siping1 Wuhai1 Dongguan Shi1 Pinggu1 Xi'an, China1 Chongli1 Beijing, China1 Beijeing1 Deyang Shi1 Foshan Shi1 Taishing1 Xiameng1 Tongchuan1 Hexi District, Tianjin1 Daping1 Pu'er1 Ezhou1 Chengxiang1 Zheng'zhou1 Heihe1 Lianyuan1 Yongji1 Hongcun1 XiAn1 Zhangjiagang1 Nayong1 Yuzhong District1 Shenyany1 Hengzhou1 Duyun1 Ordos1 Chian1 Guanghzou1 Heifei1 Maoming Shi1 Tiyuan1 Nanzhang Chengguanzhen1 Chongzuo1 Laibin1 Pinghu1 Guangxi Zhuang Autonomous Region1 Fulingqu1 Siming1 Changning1 Lingbao1 Fengcheng1 Beijjing1 Zhangye1 Yizheng1 Junxian1 Pingdu1 Zouping1 Huozhou1 Jiexiu1 Hegang1 Shuangyashan1 Suihua1 Louxing District1 Guang’an1 Dongfang1 Minhang1 Shancheng1 Yangzhou SHI1 Cangzhou Shi1 Chongging1 Linquan County1 Guangdong Province Guangzhou City1 Fenyang1 Jiayuguan1 Liangshan1 Ziyang1 Shenzhencun1 Zhaotong1 Yingtan1 Xiangshan1 Liaoyou1 Taihe1 Zhangping1 Longzhou1 Bingjie1 Gannan1 Hexi District1 Jixi1 Yangchun1 Sanjiaocheng1 Chuangchun1 Daozhen Klau and Hmong Autonomous County in Zun'yi1 Qiandongnan Miao and Dong Autonomous Region1 Jina1 Chang’an1 Cili1 Lanshan1 Leiyang1 Pingjiang1 Yangzhong1 Tianmen1 XI 'an City, Shaanxi Province1 Laizhou1 Qinhuangdao Shi1 Linyi Shi1 Linping1 Qingzhen1 Ningxiang1 Jianli City, Jingzhou City1 Jingxi1 Tengzhou Town1 Xiangyang City, Hubei Province1 Changcun1 Chongoing1 Zunhua1 Mengzhou1 Nanle1 Pizhou1 Changshang1 Yanji1 Gu'ang'zhou1 Ulanhot1 Jihan1 Hubei Sheng1 Wenshan Zhuang and Miao Autonomous Prefecture1 Anhui Sheng1 Zhongshan Town1 Yushu1 Sichuan Chengdu1 Jiangse1 Binzhou Shi1 Changhua1 Wuhang1 Gengma County1 Xian City1 Baiyin1 Xinle1 Yunlin1 Bayan Nur1 Anning, Yunnan - South Region1 Beijing, Beijing1 Cangzhou, Hebei - North Region1 Caoxian County, Shandong Province1 Changzhou, Jiangsu Province1 Chengdu, Sichuan Province1 Chongqing, Chongqing1 Chongqing, Sichuan Province1 Wu’an1 Fuding1 Zhuji1 Kaiping1 Heping1 GuiZhou1 HuBei1 HuNan1 Baoshan1 Tanjing1 Haizhu1 Shijia Zhuang1 Jiancheng1 Fuqing1 Nanping1 Tanjin1 Jiading1 Shushan1 Lanfang1 Chuxiong1 Puer1 Wenshan1 Hengshui Shi1 Dazhu1 Dingzhou1 Shang’ai1 Feixian1 Gulin1 Hanyang1 Wannan1 Beiliu1 Guidong1 Xizang1 Gongyi1 Fu'zhou1 Wuha1 Tacheng1 Longgang1 Jinghong1 Zhengjiang1 Puning1 Hongkou1 Heifi1 Changshan1 Najing1 Gui'lin1 Hshijiazhuang1 Wuhou District1 Changshashi1 Shanhu1 Xiangyun1 Xinzheng1 Hangzou1 Yongcheng1 Jining Shi1
All 625 locations
Target enrolment
to

Trials with a site in Dongguan

106 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Boehringer Ingelheim
Phase 3
270
Beijing, Chongqing, Dongguan, Guangzhou, Hefei, Luoyang, Nanchang, Nanjing
2026-12-14
Not yet open
Remimazolam vs Propofol for Long-Term Sedation in Mechanically Ventilated ICU Patients
NCT07880548Long-term Sedation for Mechanical Ventilation, Critically Ill Intensive Care Unit Patients
Sun Yat-sen University
Phase 3
274
Dongguan, Guangzhou, Shenzhen, Nanning, Luoyang, Zhengzhou, Wuhan, Nantong
2026-10-20
Not yet open
Nanfang Hospital, Southern Medical University
Phase 1/2
49
Hefei, Beijing, Fuzhou, Dongguan, Guangzhou, Huizhou, Maoming, Shenzhen
2026-10-10
Recruiting
AstraZeneca
Phase 3
2,800
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongguan
2026-09-01
Recruiting
Tasly Pharmaceutical Group Co., Ltd
Phase 3
636
Bozhou, Hefei, Suzhou, Beijing, Fuzhou, Lanzhou, Qingyang, Dongguan
2026-08-21
Not yet open
Dongguan People's Hospital
Phase 2
65
Dongguan
2026-08-10
Recruiting
AI-assisted Rare Disease Diagnosis
NCT07650799Rare Disorders, Rare Diseases
Peking Union Medical College Hospital
Not applicable
1,056
Cangzhou, Dongguan, Foshan, Guiyang, Jilin City, Kunming, Tianjin, Tianshui
2026-08-01
Recruiting
Sun Yat-sen University
Phase 3
568
Dongguan, Foshan, Guangzhou, Shenzhen, Zhongshan, Changsha
2026-07-24
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
19
Beijing, Chengdu, Dongguan, Jinan, Shanghai, Shijiazhuang, Taiyuan, Wenzhou
2026-07-20
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
156
Bozhou, Beijing, Chongqing, Dongguan, Guangzhou, Jiangmen, Shenzhen, Nanning
2026-07-16
Recruiting
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
150
Beijing, Chongqing, Fuzhou, Xiamen, Dongguan, Guangzhou, Guilin, Nanning
2026-07-15
Not yet open
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
230
Fuzhou, Xiamen, Foshan, Guangzhou, Shenzhen, Zhongshan, Nanning, Dongguan
2026-07-01
Not yet open
A Phase I Clinical Study of AK150 in Advanced Malignant Solid Tumor
NCT07566247Advanced Malignant Solid Tumors
Akeso
Phase 1
96
Fuzhou, Dongguan, Wuhan
2026-04-30
Recruiting
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2
105
Hefei, Beijing, Chongqing, Fuzhou, Dongguan, Guangzhou, Shijiazhuang, Zhengzhou
2026-04-27
Recruiting
RemeGen Co., Ltd.
Phase 3
574
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Dongguan, Guangzhou
2026-04-03
Recruiting
Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer
NCT06768931Breast Cancer, Triple Negative Breast Cancer (TNBC), Early Stage Breast Cancer, Immunotherapy
Sun Yat-sen University
Phase 2
192
Lanzhou, Dongguan, Guangzhou, Zhanjiang, Zigong
2026-04-01
Not yet open
Nanfang Hospital, Southern Medical University
Phase 4
100
Dongguan, Guangzhou, Heyuan, Qingyuan, Shaoguan, Haikou, Ganzhou
2026-04-01
Recruiting
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
NCT07477626Prostate Cancer (Post Prostatectomy), Radiotherapy; Image-Guided, Prostate Cancer Non-Metastatic, Androgen Deprivation Therapy
Sun Yat-sen University
Phase 3
372
Dongguan, Guangzhou, Zhanjiang, Zhengzhou, Chengdu, Hangzhou, Beijing, Shanghai
2026-03-20
Recruiting
Beijing Tiantan Hospital
Not applicable
376
Dongguan, Guangdong, Zhengzhou, Jinan, Jining, Ningbo, Beijing
2026-03-13
Recruiting
Sun Yat-sen University
Phase 2
243
Dongguan, Guangzhou, Shenzhen, Zhanjiang
2026-03-12
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Beijing, Changsha, Cheng Du Shi, Dongguan, Guangzhou, Hangzhou, Hefei, Jinhua
2026-03-05
Recruiting
Sanofi
Phase 3
160
Beijing, Chengdu, Dongguan, Guangzhou, Jiazhuang, Shenyang
2026-01-14
Active, closed
DIEP-MDS for Risk Stratification of Flap Vascular Compromise and Failure in Breast Reconstruction
NCT07761390Breast Neoplasms, Breast Reconstruction, Postoperative Complications
Zhuliling
Observational
1,500
Xiamen, Dongguan, Guangzhou, Huizhou, Meizhou, Shantou, Shanwei, Shaoguan
2026-01-01
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Beijing, Bengbu, Changsha, Chengdu, Chongqing, Dongguan, Guangzhou, Hangzhou
2025-12-03
Recruiting
Shanghai Henlius Biotech
Phase 1
246
Beijing, Bengbu, Changchun, Changsha, Chengdu, Dongguan, Fuzhou, Ganzhou
2025-11-25
Recruiting
GlaxoSmithKline
Phase 3
75
Leshan, Beijing, Changsha, Chengdu, Chongqing, Dongguan, Ganzhou, Guangzhou
2025-11-21
Recruiting
AstraZeneca
Observational
200
Beijing, Cangzhou, Dongguan, Fuzhou, Guangzhou, Huzhou, Jinan, Nanjing
2025-11-17
Active, closed
Sun Yat-sen University
Phase 3
700
Dongguan, Guangzhou, Shantou, Shenzhen, Zhanjiang
2025-11-17
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
202
Chongqing, Fuzhou, Xiamen, Zhangzhou, Dongguan, Guangzhou, Jiangmen, Shaoguan
2025-11-05
Recruiting
GlaxoSmithKline
Phase 2
363
Beijing, Chongqing, Dongguan, Guangzhou, Guilin, Hangzhou, Huizhou, Jiangmen
2025-10-30
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Baotou, Beijing, Bengbu, Changchun, Changsha, Chengdu, Dalian, Dongguan
2025-09-30
Not yet open
Nanfang Hospital, Southern Medical University
Phase 2/3
478
Fuzhou, Dongguan, Guangzhou, Heyuan, Hengzhou, Haikou, Ganzhou
2025-09-15
Recruiting
Liu yong
Not applicable
766
Chongqing, Dongguan, Guangzhou, Shenzhen, Zhongshan, Dalian
2025-08-12
Recruiting
AstraZeneca
Phase 2
278
Changsha, Chengdu, Deyang, Dongguan, Fuzhou, Guangzhou, Hangzhou, Hefei
2025-08-07
Not yet open
A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia
NCT07146386Benign Prostatic Hyperplasia, Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms
Shanghai Huilun Pharmaceutical Co., Ltd.
Phase 3
728
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Zhangzhou, Dongguan, Shantou
2025-08
Recruiting
DualityBio Inc.
Phase 2
750
Beijing, Dongguan, Henan, Xinxiang, Hubei, Wuhan, Changsha, Xuzhou
2025-07-18
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
216
Beijing, Dongguan, Guangdong, Guangzhou, Anyang, Zhengzhou, Wuhan, Changsha
2025-07-15
Recruiting
GlaxoSmithKline
Phase 3
981
Haikou, Changsha, Chengdu, Beijing, Changchun, Chongqing, Dongguan, Fuyang
2025-06-20
Recruiting
Sun Yat-Sen University Cancer Center
Phase 3
580
Fuzhou, Dongguan, Foshan, Guangzhou, Zhongshan, Nanning, Guiyang, Wuhan
2025-05-04
Active, closed
Guangdong Raynovent Biotech Co., Ltd
Phase 1
32
Dongguan
2025-04-14
Recruiting
Shanghai Henlius Biotech
Phase 2
70
Fuzhou, Dongguan, Guangzhou, Shenzhen, Nanning, Guiyang, Wuhan, Changsha
2025-04-02
Not yet open
Betta Pharmaceuticals Co., Ltd.
Phase 2
100
Hefei, Lanzhou, Dongguan, Foshan, Guangzhou, Baoding, Harbin, Zhengzhou
2025-03-31
Not yet open
Akeso
Phase 3
198
Wuhu, Beijing, Chongqing, Dongguan, Guangzhou, Jiangmen, Shenzhen, Zhuhai
2025-01-23
Active, closed
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809NMOSD, Neuromyelitis Optica Spectrum Disorders
DrugEculizumab
Alexion Pharmaceuticals, Inc.
Phase 3
21
Beijing, Dongguan, Jinan, Shanghai, Taiyuan, Wenzhou, Wuhan
2025-01-16
Active, closed
Janssen Research & Development, LLC
Phase 3
813
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Guangzhou, Guiyang
2025-01-09
Not yet open
Akeso
Phase 2
24
Dongguan, Guangzhou, Shenzhen, Changsha, Ningbo
2024-12-30
Recruiting
Sun Yat-Sen University Cancer Center
Phase 1/2
10
Guangzhou, Dongguan, Shanghai
2024-12-12
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 2
130
Dongguan, Guangzhou, Jinan
2024-12-06
Recruiting
Sun Yat-sen University
Not applicable
40
Guangzhou, Dongguan
2024-11-01
Recruiting
Sun Yat-sen University
Phase 2
39
Guangzhou, Lanzhou, Dongguan, Shantou, Shenzhen, Zhaoqing, Zhuhai
2024-11-01
Not yet open
Guangdong Association of Clinical Trials
Not applicable
342
Dongguan, Foshan, Guangzhou, Shenzhen, Nanning, Guiyang, Wuhan, Changsha
2024-11
Recruiting
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
308
Dongguan, Foshan, Guangzhou
2024-10-28
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Beijing, Cangzhou, Changchun, Changzhi, Chengdu, Chongqing, Dongguan, Foshan
2024-08-30
Active, closed
AstraZeneca
Phase 4
731
Beijing, Changchun, Dongguan, Foshan, Fuyang, Fuzhou, Ganzhou, Harbin
2024-08-23
Recruiting
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
NCT06535607Sub-study 1 Cervical Cancer (Volrustomig Monotherapy), Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy), Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy), Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
DrugsVolrustomig·Adrucil·Paclitaxel·Cisplatin
AstraZeneca
Phase 2
257
Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dongguan
2024-08-22
Recruiting
Guangdong Provincial People's Hospital
Phase 2
240
Dongguan, Foshan, Guangzhou, Shenzhen, Zhanjiang, Zhuhai, Haikou
2024-08-21
Active, closed
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
NCT06282874Carcinoma, Non-Small-Cell Lung, Brain Metastases, Leptomeningeal Metastasis
DrugLorlatinib
Guangdong Association of Clinical Trials
Phase 4
41
Dongguan, Foshan, Guangzhou
2024-08-01
Active, closed
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3
464
Bengbu, Hefei, Lu'an, Wuhu, Beijing, Fuzhou, Lanzhou, Dongguan
2024-06-30
Active, closed
AstraZeneca
Phase 3
339
Changchun, Changsha, Chengdu, Chongqing, Dongguan, Guangzhou, Heilongjiang, Jinan
2024-06-29
Recruiting
AstraZeneca
Phase 3
240
Beijing, Chongqing, Dongguan, Guangzhou, Hangzhou, Hengyang, Jining, Nanjing
2024-06-20
Active, closed
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 3
406
Baoding, Beijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Dongguan
2024-06-07
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Dongguan, Guangzhou, Huizhou
2024-06-05
Recruiting
AMT-116 in Patients with Solid Tumors
NCT06782334Advanced Solid Tumors
DrugAMT-116
Multitude Therapeutics Inc.
Phase 1/2
144
Fuzhou, Dongguan, Guangzhou, Nanning, Changsha, Hangzhou, Wenzhou
2024-05-07
Recruiting
CSL Behring
Phase 2/3
3,110
Baotou Shi, Beijeing, Beijing, Chengdu, Dalian, Deyang Shi, Dongguan, Foshan Shi
2024-04-27
Active, closed
AstraZeneca
Phase 3
2,554
Baotou, Beijing, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Dongguan
2024-03-29
Active, closed
TJ Biopharma Co., Ltd.
Phase 2/3
450
Anyang, Beijing, Bengbu, Binzhou, Changsha, Chongqing, Dongguan, Foshan
2024-03-28
Recruiting
GlaxoSmithKline
Phase 3
864
Chongqing, Baoding, Nanyang, Beijing, Changsha, Changzhou, Chengdu, Dongguan
2024-03-21
Recruiting
Sun Yat-sen University
Phase 2
162
Guangzhou, Dongguan, Foshan, Shenzhen, Wuhan
2024-03-19
Recruiting
AstraZeneca
Phase 3
100
Beijing, Changchun, Changsha, Dongguan, Nanjing, Shanghai, Suzhou, Wenzhou
2024-03-14
Recruiting
Sun Yat-sen University
Phase 3
593
Fuzhou, Xiamen, Dongguan, Foshan, Guangzhou, Shantou, Zhanjiang, Nanning
2024-03-01
Recruiting
Third Affiliated Hospital, Sun Yat-Sen University
Not applicable
50
Changsha, Dongguan, Guangzhou, Hangzhou, Hefei, Shenzhen
2024-01-13
Recruiting
AstraZeneca
Observational
355
Chengdu, Beijing, Changsha, Dongguan, Foshan, Guangzhou, Hainan, Hohhot
2024-01-08
Active, closed
Sanofi
Phase 3
1,655
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou
2023-12-13
Active, closed
Chronic Kidney Disease Registry Platform Study
NCT06117852Chronic Kidney Diseases
AstraZeneca
Observational
5,000
Baotou, Beijing, Changsha, Changzhou, Chengdu, Chongqing, Dongguan, Guangzhou
2023-11-28
Active, closed
AstraZeneca
Phase 3
1,898
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Guangzhou, Guilin
2023-11-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Dongguan, Guangzhou, Huizhou
2023-10-25
By invitation
Biogen
Phase 3
306
Beijing, Shenzhen, Dongguan, Guangzhou, Changsha, Nanjing, Shanghai, Kunming
2023-10-03
Active, closed
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
990
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Dongguan, Foshan, Guangzhou
2023-09-22
Active, closed
Pfizer
Phase 2
507
Beijing, Fuzhou, Dongguan, Guangzhou, Shijiazhuang, Changsha, Wuhan, Nanchang
2023-08-22
Active, closed
Sun Yat-sen University
Not applicable
620
Beijing, Fuzhou, Lanzhou, Dongguan, Foshan, Guangzhou, Wuhan, Nanjing
2023-08-16
Active, closed
Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
NCT05780372Nasopharyngeal Carcinoma, Radiotherapy; Complications
Sun Yat-sen University
Phase 3
474
Chongqing, Dongguan, Guangzhou, Liuzhou, Nanning, Nanchang, Hangzhou
2023-08-08
Active, closed
Sun Yat-sen University
Phase 3
490
Bengbu, Hefei, Beijing, Fuzhou, Dongguan, Guangzhou, Zhongshan, Nanning
2023-08-01
Not yet open
Nanfang Hospital, Southern Medical University
Observational
2,592
Fuzhou, Dongguan, Guangzhou, Heyuan, Huizhou, Haikou, Changsha, Hengyang
2023-07-01
Active, closed
OncoC4, Inc.
Phase 3
630
Hefei, Beijing, Fuzhou, Xiamen, Dongguan, Guangzhou, Nanning, Haikou
2023-06-28
Recruiting
Pfizer
Phase 3
318
Hefei, Beijing, Dongguan, Guangzhou, Cangzhou, Changsha, Nanjing, Nanchang
2023-05-20
Recruiting
Nanfang Hospital, Southern Medical University
Observational
2,592
Fuzhou, Dongguan, Guangzhou, Heyuan, Huizhou, Haikou, Changsha, Hengyang
2023-05-01
Recruiting
The First Affiliated Hospital with Nanjing Medical University
Phase 4
2,260
Nanjing, Changzhou, Chongqing, Dalian, Daqing, Dongguan, Fengcheng, Guangzhou
2023-04-08
Active, closed
Amgen
Observational
7,000
Beijing, Chongqing, Dongguan, Foshan, Guangzhou, Huizhou, Zhuhai, Guilin
2022-12-19
Active, closed
Bellus Health Inc. - a GSK company
Phase 3
997
Kunshan, Leshan, Ürümqi, Beijing, Changsha, Chengdu, Chongqing, Dongguan
2022-12-05
Recruiting
Sun Yat-sen University
Observational
800
Fuzhou, Dongguan, Foshan, Guangzhou, Shantou, Shaoguan, Shenzhen, Zhongshan
2022-10-10
Active, closed
Biogen
Phase 2/3
450
Beijing, Chongqing, Fuzhou, Dongguan, Guangzhou, Shenzhen, Zhongshan, Nanyang
2022-09-13
Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
348
Fuzhou, Dongguan, Guangdong, Zhengzhou, Wuhan, Jinan, Hangzhou
2022-08-09
Active, closed
DualityBio Inc.
Phase 1/2
1,123
Bengbu, Hefei, Fuzhou, Lanzhou, Dongguan, Guangzhou, Guigang, Nanning
2022-07-19
By invitation
Biogen
Phase 3
864
Beijing, Dongguan, Guangzhou, Shenzhen, Zhongshan, Haikou, Shijiazhuang, Changsha
2022-06-10
Recruiting
Sun Yat-sen University
Phase 2
280
Changchun, Chengdu, Dongguan, Dongyang, Foshan, Guangzhou, Hangzhou, Jiangmen
2022-05-06
Active, closed
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2
25
Zhuhai, Dongguan
2022-03-09
Active, closed
Sanofi
Phase 4
1,339
Beijing, Dongguan, Guangzhou, Guiyang, Hebei, Hefei, Nanchang, Nanjing
2021-12-16
Recruiting
Sunshine Lake Pharma Co., Ltd.
Phase 2/3
600
Dongguan
2021-12-14
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Bengbu, Changsha, Chengdu, Dongguan, Fuzhou, Guangzhou, Jinan, Linyi
2021-12-10
Active, closed
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
36
Bengbu, Dongguan, Guangzhou, Changsha, Chengdu
2021-11-26
Recruiting
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
NCT05024214Solid Tumors, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma
DrugsEnvafolimab·Sunitinib·Lenvatinib
3D Medicines (Sichuan) Co., Ltd.
Phase 1/2
170
Bengbu, Beijing, Fuzhou, Xiamen, Dongguan, Guangzhou, Zhuhai, Haerbin
2021-11-15
Active, closed
Akeso
Phase 3
296
Hefei, Fuzhou, Xiamen, Dongguan, Guangzhou, Jiangmen, Shantou, Shenzhen
2021-08-16
Active, closed
Biogen
Phase 3
562
Beijing, Dongguan, Guangzhou, Shenzhen, Haikou, Changsha, Zhuzhou, Wuhan
2021-07-16
Active, closed
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Phase 4
2,500
Hefei, Beijing, Chongqing, Xianmencun, Dongguan, Guangzhou, Shenzhen, Zhuhai
2021-06-02
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Dongguan, Fuzhou, Baotou, Nanjing, Nantong, Shanghai, Chengdu, Ürümqi
2020-12-11
Active, closed
ASPIrin in Reducing Events in Dialysis ( ASPIRED )
NCT04381143CKD (Chronic Kidney Disease) Stage 5D
DrugAspirin
Guangdong Provincial People's Hospital
Phase 4
9,082
Fuzhou, Longyan, Lanzhou, Dongguan, Foshan, Guangzhou, Guanzhou, Heyuan
2020-07-30
Rows per page Showing 1–106 of 106
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/dongguan

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 106 of those studies with a site in Dongguan.

How many clinical trials are recruiting in Dongguan?

55 of the 106 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 14 have not yet opened recruitment, 35 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Dongguan), 106 studies
PhaseStudiesRecruitingShare
Phase 3431940.6%
Phase 2211519.8%
Not applicable867.5%
Observational847.5%
Phase 1/2746.6%
Phase 4716.6%
Phase 1635.7%
Phase 2/3635.7%

Most active sponsors

Lead sponsors with the most studies (Dongguan)
Lead sponsorStudiesRecruiting
Sun Yat-sen University1510
AstraZeneca127
Nanfang Hospital, Southern Medical University51
Akeso40
Biogen40
GlaxoSmithKline44
Janssen Research & Development, LLC32
Sanofi31
Alexion Pharmaceuticals, Inc.21
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.